Journal of nephrology
-
Journal of nephrology · Sep 2011
Multicenter Study Clinical TrialIron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease.
Patients with chronic kidney disease (CKD) often suffer from iron deficiency anemia necessitating treatment with intravenous iron. This study was designed to assess the safety of iron isomaltoside 1000 (Monofer) in CKD patients. The secondary objective was to assess its effect on iron deficiency anemia. ⋯ Iron isomaltoside 1000 was clinically well tolerated, safe and effective. This new intravenous iron may offer a further valuable choice in treating the anemia of CKD.